BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:32386536-3033-4534-b335-323732326135
BEGIN:VEVENT
UID:564a65e5b75654b03def403a8d44f610e61acb26@swoogo.com
DTSTAMP:20260810T051457Z
DESCRIPTION:Incarcerated individuals with serious mental health conditions 
 often face co-occurring medical issues. This session reviews key elements 
 of chronic care visits for patients with psychosis and mood disorders\, em
 phasizing collaboration between medical and mental health providers. Topic
 s include minimizing polypharmacy\, managing medication interactions\, and
  adopting a patient-centered\, team-based approach to reduce the risk of m
 etabolic syndrome and improve overall outcomes.\n\nEducational Objectives
 \n\n 	* Identify concomitant medical conditions that place patients at incr
 eased risk for serotonin syndrome\n 	* Describe how to recognize and addres
 s common MAT side effects\n 	* Discuss the increased risk of metabolic synd
 rome associated with antipsychotics and mood stabilizers\n\nLevel:Intermed
 iate
DTSTART:20250720T171500Z
DTEND:20250720T181500Z
LAST-MODIFIED:20260810T051457Z
LOCATION:Continental 6
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:304 Minimizing Polypharmacy and Metabolic Risk: Collaborative Care 
 for Psychosis and Mood Disorders
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p>Incarcerated individuals with serious menta
 l health conditions often face co-occurring medical issues. This session r
 eviews key elements of chronic care visits for patients with psychosis and
  mood disorders\, emphasizing collaboration between medical and mental hea
 lth providers. Topics include minimizing polypharmacy\, managing medicatio
 n interactions\, and adopting a patient-centered\, team-based approach to 
 reduce the risk of metabolic syndrome and improve overall outcomes.</p>\n
 \n<p>Educational Objectives</p>\n\n<ul>\n	<li>Identify concomitant medical 
 conditions that place patients at increased risk for serotonin syndrome</l
 i>\n	<li>Describe how to recognize and address common MAT side effects</li>
 \n	<li>Discuss the increased risk of metabolic syndrome associated with ant
 ipsychotics and mood stabilizers</li>\n</ul>\n\n<p>Level:Intermediate</p>
BEGIN:VALARM
UID:62376533-3361-4031-a566-326566303335
ACTION:DISPLAY
DESCRIPTION:Incarcerated individuals with serious mental health conditions 
 often face co-occurring medical issues. This session reviews key elements 
 of chronic care visits for patients with psychosis and mood disorders\, em
 phasizing collaboration between medical and mental health providers. Topic
 s include minimizing polypharmacy\, managing medication interactions\, and
  adopting a patient-centered\, team-based approach to reduce the risk of m
 etabolic syndrome and improve overall outcomes.\n\nEducational Objectives
 \n\n 	* Identify concomitant medical conditions that place patients at incr
 eased risk for serotonin syndrome\n 	* Describe how to recognize and addres
 s common MAT side effects\n 	* Discuss the increased risk of metabolic synd
 rome associated with antipsychotics and mood stabilizers\n\nLevel:Intermed
 iate
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR
